Answers are grounded in this paper and cite their sources.
The management of coronavirus disease-2019 (COVID-19) is witnessing a change as we learn more about the pathophysiology and the severity of the disease.Several randomized controlled trials (RCTs) and meta-analysis have been published over the last few months.Several interventions and therapies which showed promise in the initial days of the pandemic have subsequently failed to show benefit in well-designed trials.Understanding of the methods of oxygen delivery and ventilation have also evolved over the past few months.The Indian Society of Critical Care Medicine (ISCCM) has reviewed the evidence that has emerged since the publication of its position statement in May and has put together an addendum of updated evidence.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: